Table 3.
Self-assessed impact of Clostridioides difficile infection (CDI) on participants’ chronic conditions
| Current CDI, n (%) | Negative impact of CDI, n (%) | Past CDI, n (%) | Negative impact of CDI, n (%) | |
|---|---|---|---|---|
| (n = 115) | (n = 235) | |||
| ≥ 1 chronic disease | 51 (44.3%) | N/A | 125 (53.2%) | N/A |
| Alzheimer’s disease or related disease | 0 (0%) | N/A | 0 (0%) | N/A |
| Arthritis | 13 (11.3%) | 9 (69.2%) | 41 (17.4%) | 24 (58.5%) |
| Cancer | 4 (3.5%) | 1 (25.0%) | 6 (2.6%) | 3 (50.0%) |
| COPD and allied conditions | 5 (4.3%) | 1 (20.0%) | 12 (5.1%) | 3 (25.0%) |
| Depression | 17 (14.8%) | 12 (70.6%) | 46 (19.6%) | 42 (91.3%) |
| Diabetes | 7 (6.1%) | 1 (14.3%) | 12 (5.1%) | 5 (41.7%) |
| Heart disease | 3 (2.6%) | 1 (33.3%) | 11 (4.7%) | 1 (9.1%) |
| High blood pressure | 13 (11.3%) | 5 (38.5%) | 40 (17.0%) | 15 (37.5%) |
| IBD | 11 (9.6%) | 9 (81.8%) | 26 (11.1%) | 23 (88.5%) |
| IBS | 10 (8.7%) | 8 (80.0%) | 49 (20.9%) | 43 (87.8%) |
| Osteoporosis | 6 (5.2%) | 2 (33.3%) | 20 (8.5%) | 8 (40.0%) |
| Stroke | 2 (1.7%) | 1 (50.0%) | 3 (1.3%) | 1 (33.3%) |
| Other | 28 (24.3%) | N/A | 58 (24.7%) | N/A |